(2-Methylpiperidin-4-yl) propanoate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (2-Methylpiperidin-4-yl) propanoate
• 英文别名: (2-methylpiperidin-4-yl) propanoate
• 化学式: C₉H₁₇NO₂
• 分子量: 171.24
• InChiKey: WPQBWKLVQWAMTO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] CONDURITOL AZIRIDINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS D'AZIRIDINE DE CONDURITOL ET LEURS UTILISATIONS
  申请人：UNIV SASKATCHEWAN

  公开号：WO2019075574A1

  公开（公告）日：2019-04-25

  The present application relates to conduritol aziridines of Formula (I), and uses thereof, for example, of 18F-labelled derivatives thereof in positron-emission tomography (PET) imaging of β-glucocerebrosidase activity.

  本申请涉及式(I)的康杜糖异丙环烷以及其用途，例如18F标记衍生物在β-葡萄糖鞘脂酶活性的正电子发射断层扫描（PET）成像中的应用。
• GERANIUM OIL AND CONSTITUENTS THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES
  申请人：The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center)

  公开号：EP2846815A1

  公开（公告）日：2015-03-18
• Geranium oil and constituents thereof for treatment of neurodegenerative diseases
  申请人：The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization

  公开号：US20200188320A1

  公开（公告）日：2020-06-18

  The invention relates to the use of effective amount of Pelargonium graveolens essential oil or extract or constituents thereof selected from a group consisting of: (S)(−)citronellol, linalool, menthone and isomenthone or any combination thereof, in the preparation of a medicament for treating a mammal suffering from or susceptible to a neurodegenerative condition which can be improved or prevented by inhibition of acetylcholinesterase (ACliE).
• [EN] GERANIUM OIL AND CONSTITUENTS THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES<br/>[FR] HUILE DE GÉRANIUM ET SES CONSTITUANTS DESTINÉS AU TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
  申请人：ISRAEL STATE

  公开号：WO2013168090A1

  公开（公告）日：2013-11-14

  The invention relates to the use of effective amount of Pelargonium graveolens essential oil or extract or constituents thereof selected from a group consisting of: (S)(-)citroneIlol, linalool, menthone and isomenthone or any combination thereof, in the preparation of a medicament for treating a mammal suffering from or susceptible to a neurodegenerative condition which can be improved or prevented by inhibition of acetylcholinesterase (ACliE).